SS
MDGL icon

Steve Schonfeld’s Madrigal Pharmaceuticals MDGL Stock Holding History

Steve Schonfeld’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-60,000
Closed -$237K – 2355
2023
Q1 		$237K Buy
60,000
+10,000
+20% +$2.72M ﹤0.01% 1469
2022
Q4 		$908K Sell
50,000
-45,300
-48% -$4.43M 0.01% 1202
2022
Q3 		$812K Buy
+95,300
New +$6.62M 0.01% 1422

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Steve Schonfeld's MDGL Position: Q2 2026 in Review

Steve Schonfeld opened a new position in Madrigal Pharmaceuticals (MDGL) in Q2 2026: 1,862 shares worth $1,000K. The stake represents ﹤0.01% of the portfolio and ranks #1481 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in MDGL as recently as Q1 2025.

Steve Schonfeld first reported a position in MDGL in Q1 2018 and has held it in 24 quarters since. The position peaked at $12.8M in Q3 2018. 411 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Steve Schonfeld held 1,862 shares of Madrigal Pharmaceuticals worth $1,000K as of Q2 2026.
  • Madrigal Pharmaceuticals was a new Steve Schonfeld position in Q2 2026.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #1481 holding.
  • Steve Schonfeld first reported a position in Madrigal Pharmaceuticals in Q1 2018 and has held it in 24 quarters since.
  • Steve Schonfeld's Madrigal Pharmaceuticals position peaked at $12.8M in Q3 2018.
  • 411 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.